Skip to NavigationSkip to content

News

Contamination fears over Mylan's household-name anxiety drug Xanax, UKRI and BBSRC gives cash injection to cultivate pharma and biotech PhDs in the...
Elderly patients are being put at risk by prescriptions for drugs which have not been properly tested in their age group through clinical trials, a...
A new report has revealed that GPs in England are writing fewer prescriptions for antibiotics, but this has done little to halt the spread of...
Amgen has signed an agreement with Chinese biotech BeiGene to acquire a 20.5% stake in the latter, in a bid to “significantly accelerate” the...
Novartis has announced new data drawn from a trial pitting Cosentyx (secukinumab) in head-to-head competition with AbbVie’s Humira (adalimumab) –...
AbbVie has unveiled new Phase 3 data on two doses of its JAK inhibitor Rinvoq (upadacitinib), showing that the therapy met its primary endpoint in...
Catalyst Pharmaceuticals has made it known that its lead product Firdapse (Amifampridine Phosphate) fell short of its primary endpoint in the...
The trio of Galapagos, MorphoSys and Novartis Pharma has revealed that all further development of its MOR106 drug candidate for the treatment of...
David Eatwell, Executive Vice President and Chief Financial Officer at Genmab, has announced his intention to step down from the role next year,...
An FDA committee has passed a contentious vote recommending by a slim majority for the withdrawal of existing approval of AMAG Pharmaceuticals’...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches